Evaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF)
Authors:
- Sébastien L’HErmiteSLSébastien L’HErmite
- Isaure BreteauIBIsaure Breteau
- Sébastien HalterSHSébastien Halter
- Nicolas JacquinotNJNicolas Jacquinot
- Valentin CoirierVCValentin Coirier
- José Ursic-BedoyaJUJosé Ursic-Bedoya
- Giovanni PerriconeGiovanni Perricone
- Laure ElkriefLELaure Elkrief
- Philippe IchaiPIPhilippe Ichai
- Audrey CoillyACAudrey Coilly
- Sophie-Caroline SacleuxSSSophie-Caroline Sacleux
- Pauline Houssel-DebryPHPauline Houssel-Debry
Open Access
- 8 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
Abstract
The Transplantation for ACLF-3 Model (TAM) and Sundaram ACLF-LT-Mortality score (SALT-M) have been proposed to help select liver transplantation (LT) candidates with acute-on-chronic liver failure (ACLF) to optimize post-LT outcomes. We assessed the performance and clinical utility of these scores and their components on a large retrospective international multicenter study. All patients transplanted in the context of ACLF grade 3 (n=336) from 9 international cohorts (2008–2024) were included in the study. The primary endpoint was 1-year post-LT survival. Score discrimination, calibration, and clinical utility using decision-curve (net benefit) analysis were assessed. The 1-year post-LT survival rate was 75.3%. Both TAM (OR 1.91, p =0.0001) and SALT-M (OR 1.09, p 25 (46.9% vs. 78.7%). Respiratory failure (PaO 2 /FiO 2 ≤200) was associated with 1-year post-LT mortality, whereas other variables included in the original scores, diabetes, BMI, and leukocyte count, did not demonstrate significant prognostic value in this cohort. In this large multicenter study, TAM and SALT-M were associated with post-LT mortality but demonstrated limited discriminative accuracy. Candidate high-risk thresholds (TAM ≥3, SALT-M >25) may help identify a small subset of patients with markedly poor post-LT outcomes. However, given their modest performance, these scores should support, not replace, multidisciplinary decision-making, and their applicability should be evaluated in a prospective fashion.Keywords
This publication has 20 references indexed in Scilit:
- Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisationThe Lancet Regional Health - Europe, 2024
- The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failureJournal of Hepatology, 2023
- Should patients with acute-on-chronic liver failure grade 3 receive higher priority for liver transplantation?Journal of Hepatology, 2023
- Location and allocationLiver Transplantation, 2022
- Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)Journal of Hepatology, 2021
- Pretransplant Intensive Care Unit Management and Selection of Grade 3 Acute‐on‐Chronic Liver Failure Transplant CandidatesLiver Transplantation, 2021
- Minimum sample size for external validation of a clinical prediction model with a binary outcomeStatistics in Medicine, 2021
- Liver transplantation in patients with multiple organ failures: Feasibility and outcomesJournal of Hepatology, 2018
- Potentially inappropriate liver transplantation in the era of the “sickest first” policy – A search for the upper limitsJournal of Hepatology, 2018
- Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3Journal of Hepatology, 2017